Certified by Founder Lodge
AOA Dx
United States - Boulder, CO
START UP
1 Disclosed Funding Rounds $17,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AOA Dx is developing the next frontier in early-stage cancer detection through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglios
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 13 ,2023 | Unknown | $17,000,000 |
The Helm
VU Venture Partners
Labcorp
RH Capital
Good Growth Capital
Astia
Gore Range Capital
LongeVC
FemHealth Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Elly | $8,000,000 | (Feb 26, 2026)
Quill Meetings | $6,500,000 | (Feb 26, 2026)
Abram Scientific | $11,750,000 | (Feb 26, 2026)
Cicada | $13,500,000 | (Feb 26, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)